Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation

Marc Galimand1, Patrice Courvalin, Thierry Lambert

  • 1Unité des Agents Antibactériens, Institut Pasteur, 75724 Paris Cedex 15, France. galimand@pasteur.fr

Insights

A novel gene, armA, found on a plasmid in Klebsiella pneumoniae, confers high-level resistance to multiple aminoglycoside antibiotics. This discovery highlights a new mechanism for antibiotic resistance in gram-negative pathogens.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • The emergence of antibiotic resistance in bacterial pathogens poses a significant global health threat.
  • Klebsiella pneumoniae is a common cause of hospital-acquired infections, often exhibiting multidrug resistance.

Purpose of the Study:

  • To identify and characterize the genetic basis of multidrug resistance in a clinical isolate of Klebsiella pneumoniae.
  • To investigate the function and origin of a novel aminoglycoside resistance gene.

Main Methods:

  • Plasmid isolation and characterization (pIP1204, ~80 kb).
  • Gene identification for resistance to beta-lactams, trimethoprim, sulfonamides, streptomycin-spectinomycin, and aminoglycosides.
  • Cloning of the novel gene 'armA' into Escherichia coli to assess its function.
  • Sequence analysis of the armA gene and comparison with known resistance genes.

Main Results:

  • The plasmid pIP1204 conferred resistance to multiple antibiotics, including beta-lactams, trimethoprim, sulfonamides, streptomycin-spectinomycin, and various aminoglycosides.
  • A newly identified gene, armA, was responsible for high-level resistance to specific aminoglycosides and fortimicin when expressed in E. coli.
  • Sequence analysis revealed ArmA shares similarity with 16S rRNA methyltransferases but its low GC content suggests a non-actinomycete origin.

Conclusions:

  • The novel armA gene confers significant, broad-range aminoglycoside resistance in gram-negative bacteria.
  • Posttranscriptional modification of 16S rRNA is a viable mechanism for high-level aminoglycoside resistance.
  • Understanding these resistance mechanisms is crucial for developing strategies against multidrug-resistant pathogens.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...
Plasmids01:28

Plasmids

Plasmids are extrachromosomal DNA molecules found in bacteria, archaea, and some eukaryotic microbes like yeast. These small, circular DNA structures typically contain fewer than 30 genes, although some may exist linearly. Plasmids vary in their number within a cell, known as copy number. Single-copy plasmids are present in one copy per cell and multi-copy plasmids are present in multiple copies, reaching over 100 copies per cell.Plasmids usually replicate independently of the chromosomal DNA...
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...